Abstract:The current experiments aimed to develop an anti-glioblastoma multiforme (GBM) formulation based on rutin-loaded nanomicelles. First, the molecular structure of water, and ethanol was constructed using Material Studio software. Then, the structure of the molecules was optimized through the Forcite module in the software. In sequence, to set the temperature of the system the MD simulations were run under the NVT ensemble (constant number of particles, volume, and temperature) with velocity scale as a thermostat and total simulation time equal to 100 ps as the initialization step. We applied the hydrophobic-hydrophobic interactions and micellization process method to encapsulate rutin into micellar nanoparticles. The computational studies showed that in the first 30 ps of the simulation the system is unstable, but after that, the system reached a stable condition. Moreover, we observed that the density of the system rapidly decreased from 0.98 g/cm 3 to a stable mean value equal to 0.95 g/cm 3 . The characterizations using DLS and SEM imaging showed that the synthesized NPs have a size lower than 100 nm. The hemolysis evaluation showed that the Rut-micelles are hemocompatible and induced lower than 10% hemolysis in all tested groups. The highest cell lethality was observed in the group treated with the synthesized Rut-micelles with a concentration of 400μM, which was statistically significant (p < 0.05) to the control and other test groups. The anti-metastatic effect of the Rut-micelles was confirmed via the cell monolayer wound scratch assay. These results illustrated that the synthesized rutin-loaded nanomicelles could be applied as a GBM treatment option to improve the treatment efficiency of glioblastoma multiforme. Graphical abstract Download : Download high-res image (385KB) Download : Download full-size image

Synergic fabrication of dual drug-loaded polymeric nanoparticles system to improve the in vitro treatment of glioma metastasis specific targeting therapy

Interpreting the Therapeutic Efficiency of Multifunctional Hybrid Nanostructure Against Glioblastoma

Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma

Synergetic Therapy of Glioma Mediated by a Dual Delivery System Loading Α-Mangostin and Doxorubicin Through Cell Cycle Arrest and Apoptotic Pathways

Dual Targeting of Glioma U251 Cells with Nanoparticles Prevents Tumor Angiogenesis and Inhibits Tumor Growth

Synthesis and characterization of rutin-loaded micelles for glioblastoma multiforme treatment: A computational and experimental study

Precise engineering of Iguratimod and Rapamycin drugs loaded polymeric nanomaterials for the treatment of glioma cancer cells

Precise engineering of dual drug-loaded polymeric nanoparticles system to improve the treatment of glioma-specific targeting therapy

Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment.

Synergistic inhibitory characteristics of doxorubicin and gossypol dual-drugs nanocarriers for U87 glioma cell

A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care

iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy

WITHDRAWN: Precise Engineering of Iguratimod and Rapamycin Drugs Loaded Polymeric Nanomaterials for the Treatment of Glioma Cancer Cells

Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy

Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.

Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability

A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy

Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma

Glioma Targeting and Anti-Glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles.

Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology

Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo .